Morgan Stanley’s ETRACS Alerian MLP Index ETN Series B due July 18 2042 AMUB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.7K Sell
1,508
-4,356
-74% -$91.1K ﹤0.01% 6562
2025
Q4
$111K Hold
5,864
﹤0.01% 6148
2025
Q3
$109K Sell
5,864
-18
-0.3% -$344 ﹤0.01% 6117
2025
Q2
$113K Sell
5,882
-1,257
-18% -$23.8K ﹤0.01% 6088
2025
Q1
$146K Sell
7,139
-3
-0% -$60 ﹤0.01% 5856
2024
Q4
$132K Sell
7,142
-7
-0.1% -$129 ﹤0.01% 5942
2024
Q3
$128K Sell
7,149
-15
-0.2% -$270 ﹤0.01% 5902
2024
Q2
$130K Sell
7,164
-7
-0.1% -$124 ﹤0.01% 5866
2024
Q1
$129K Sell
7,171
-8,979
-56% -$152K ﹤0.01% 5891
2023
Q4
$258K Buy
16,150
+8,956
+124% +$142K ﹤0.01% 5850
2023
Q3
$112K Sell
7,194
-8
-0.1% -$121 ﹤0.01% 5845
2023
Q2
$104K Buy
7,202
+2,486
+53% +$35.2K ﹤0.01% 5938
2023
Q1
$65.9K Sell
4,716
-5
-0.1% -$71 ﹤0.01% 6176
2022
Q4
$64.6K Sell
4,721
-1,075
-19% -$14.9K ﹤0.01% 6176
2022
Q3
$73K Sell
5,796
-7,767
-57% -$102K ﹤0.01% 6230
2022
Q2
$161K Buy
13,563
+13,160
+3,266% +$175K ﹤0.01% 5994
2022
Q1
$5K Sell
403
-3
-0.7% -$38 ﹤0.01% 7571
2021
Q4
$5K Sell
406
-725
-64% -$8.43K ﹤0.01% 7629
2021
Q3
$13K Buy
1,131
+712
+170% +$8.14K ﹤0.01% 7240
2021
Q2
$5K Sell
419
-386
-48% -$4.52K ﹤0.01% 7369
2021
Q1
$8K Buy
805
+362
+82% +$3.62K ﹤0.01% 7004
2020
Q4
$4K Sell
443
-13
-3% -$106 ﹤0.01% 6792
2020
Q3
$3K Hold
456
﹤0.01% 6502
2020
Q2
$4K Sell
456
-12
-3% -$100 ﹤0.01% 6327
2020
Q1
$3K Buy
+468
New +$5.16K ﹤0.01% 6305

Other funds holding AMUB

Morgan Stanley's AMUB Position: Q1 2026 in Review

Morgan Stanley reduced its ETRACS Alerian MLP Index ETN Series B due July 18 2042 (AMUB) stake by 74% in Q1 2026, selling an estimated $91.1K and leaving 1,508 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6562.

Morgan Stanley first reported a position in AMUB in Q1 2020 and has held it in 25 quarters since. The position peaked at $258K in Q4 2023. 7 funds tracked by Wall St. Rank hold AMUB as of Q1 2026.

  • Morgan Stanley held 1,508 shares of ETRACS Alerian MLP Index ETN Series B due July 18 2042 worth $32.7K as of Q1 2026.
  • Morgan Stanley sold 4,356 ETRACS Alerian MLP Index ETN Series B due July 18 2042 shares in Q1 2026, an estimated $91.1K.
  • ETRACS Alerian MLP Index ETN Series B due July 18 2042 made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6562 holding.
  • Morgan Stanley first reported a position in ETRACS Alerian MLP Index ETN Series B due July 18 2042 in Q1 2020 and has held it in 25 quarters since.
  • Morgan Stanley's ETRACS Alerian MLP Index ETN Series B due July 18 2042 position peaked at $258K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held ETRACS Alerian MLP Index ETN Series B due July 18 2042 as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.